Home > About Us > Our History

• Haohai Limited was established
• Gained control of Songjiang Biopharmaceutical Factory
• Shanghai Jianhua was acquired
• Shanghai Qisheng was acquired

• Haohai Limited was converted into a joint stock limited liability company and renamed to Shanghai Haohai Biological Technology Co., Ltd
• Acquired Shanghai Likangrui and expaned product lines in the anti-adhesion and hemostasis area

• Sponsor the establishment of the Shanghai Strategic Alliance for Innovation of Medical Absorbable Biomaterial

• Recognized as an enterprise technology center by government authorities in Shanghai

• Established the Shanghai Engineering and Research Center of Medical Absorbable Biomaterial
• Completed the construction of new production lines (Songjiang Factory) and obtained the new GMP license
• Completed renovation and upgrades of the production facilities at Shanghai Qisheng
• Completed the construction of buildings and civil engineering works of Shanghai Likangrui

• Listed on the Hong Kong Exchange on April 30
  Stock Code:6826.HK
• Established the "postdoctoral science research workstation"
• Established "Shanghai Academician and Expert Workstation"

Invested RMB 510 million to establish an ophthalmology integration and  development platform
Acquired 60% equity interests of Shenzhen NIMO
Acquired 98% equity interests of Zhuhai Eyegood
Acquired 100% equity interests of Henan Universe
Completed acquisition of Aaren Business of the hydrophilic and PMMA intraocular lens

Acquired 70% equity interests of Contamac

• Included in the National Enterprise Technology Centers
• Awarded the title of Intellectual Property Right Demonstration Enterprise of China


All Rights Reserved | Haohai Biological Technology | People's Republic of China Internet Medical Products Information Qualification Certificate | Certificate No: (Hu) – Non-Operative-2018-0079

Copyright © 2015-2018 All Rights Reserved Website by Globalquincy.com